MILANI ERASE BASE BLEMISH CONTROL PRIMER Salicylic Acid

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
MILANI ERASE BASE BLEMISH CONTROL PRIMER Salicylic Acid
Generic name
SALICYLIC ACID
Manufacturer
New Milani Group, LLC
Product type
HUMAN OTC DRUG
SPL set ID
c2d43609-8a7a-4e54-8e8c-66115948dba2
SPL ID
0c5cff9a-f83a-7fae-e063-6294a90a7737
Version
3
Effective date
2023-12-12
Source export date
2026-11-06
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/245ea1c0d730b312e4410f082201cbe2cb4d1936fa2918316b6ea631293cbeba/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 08:08:16
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.